Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 3 (2007), Issue 9 (September)

1. Non-[18F]FDG PET in clinical oncology.
   Lancet Oncol, 8(9): 822-30. [Abstract] [Full-text]
2. Consensus on a core curriculum in American training programs in pediatric hematology-oncology: a report from the ASPHO Training Committee.
   Pediatr Hematol Oncol, 24(7): 503-12. [Abstract] [Full-text]
3. Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study.
   J Pediatr Hematol Oncol, 29(9): 627-32. [Abstract] [Full-text]
4. Preparing to sit the Royal Australia and New Zealand College of Radiologists Faculty of Radiation Oncology Fellowship Part 2 examination: the value of a workshop including practice and feedback.
   Australas Radiol, 51(5): 465-71. [Abstract] [Full-text]
5. Oncology for medical students: A European School of Oncology contribution to undergraduate cancer education.
   Cancer Treat Rev, 33(5): 419-26. [Abstract] [Full-text]
6. Accelerated partial breast irradiation: consensus statement of 3 German Oncology societies.
   Cancer, 110(6): 1187-94. [Abstract] [Full-text]
7. Magnetic resonance imaging of bone marrow in oncology, Part 1.
   Skeletal Radiol, 36(10): 913-20. [Abstract] [Full-text]
8. Pediatric oncology nurses' attitudes related to discussing fertility preservation with pediatric cancer patients and their families.
   J Pediatr Oncol Nurs, 24(5): 255-63. [Abstract] [Full-text]
9. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology.
   J Clin Oncol, 25(26): 4104-9. [Abstract] [Full-text]
10. Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer Michaelson MD, Kaufman DS, Lee H, McGovern FJ, Kantoff PW, Fallon MA, Finkelstein JS, Smith MR, Division of Hematology and Oncology and Endocrine Unit, Massachusetts General Hospital, Boston, MA.
    Urol Oncol, 25(5): 446. [Abstract] [Full-text]
11. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT investigators Beer TM, Ryan CW, Venner PM, Petrylak DP, Chatta GS, Ruether JD, Redfern CH, Fehrenbacher L, Saleh MN, Waterhouse DM, Carducci MA, Vicario D, Dreicer R, Higano CS, Ahmann FR, Chi KN, Henner WD, Arroyo A, Clow FW, ASCENT Investigators, Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health and Science University, Portland, OR.
    Urol Oncol, 25(5): 445-6. [Abstract] [Full-text]
12. Optimal phase I dose-escalation trial designs in oncology-A simulation study.
    Stat Med. [Abstract] [Full-text]
13. Does vicarious traumatisation affect oncology nurses? A literature review.
    Eur J Oncol Nurs, 11(4): 348-56. [Abstract] [Full-text]
14. The lived experience of Lebanese oncology patients receiving palliative care.
    Eur J Oncol Nurs, 11(4): 309-19. [Abstract] [Full-text]
15. Ontario radiation oncology residents' needs in the first postgraduate year-residents' perspective survey.
    Int J Radiat Oncol Biol Phys, 69(2): 512-7. [Abstract] [Full-text]
16. Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
    Chest, 132(3): 340S-354S. [Abstract] [Full-text]
17. Use of Patient-Reported Outcomes in Clinical Oncology Practice: A Nonvisit Approach to Patient Care Based on the IOM Report.
    J Ambul Care Manage, 30(4): 302-7. [Abstract] [Full-text]
18. Critical evaluation of nutrition screening tools recommended for oncology patients.
    Cancer Nurs, 30(5): E1-6. [Abstract] [Full-text]
19. A Phase I Study of 90Yttrium-Ibritumomab-Tiuxetan in Children and Adolescents with Relapsed/Refractory CD20-Positive Non Hodgkin's Lymphoma: A Children's Oncology Group Study.
    Clin Cancer Res, 13(18): 5652s-60s. [Abstract] [Full-text]
20. Outcome of children treated with preradiation chemotherapy for a high-grade glioma: results of a French Society of Pediatric Oncology (SFOP) Pilot Study.
    Pediatr Blood Cancer, 49(6): 803-7. [Abstract] [Full-text]
21. Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience.
    Int J Gynecol Cancer, 17(5): 1003-10. [Abstract] [Full-text]
22. Current approaches for risk stratification of infectious complications in pediatric oncology.
    Pediatr Blood Cancer, 49(6): 767-73. [Abstract] [Full-text]
23. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Neuro Oncol, 9(4): 430-7. [Abstract] [Full-text]
24. Risks and benefits associated with novel phase 1 oncology trial designs.
    Cancer, 110(5): 1115-24. [Abstract] [Full-text]
25. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.
    Cancer, 110(5): 1003-9. [Abstract] [Full-text]
26. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Ann Surg Oncol, 14(10): 2928-31. [Abstract] [Full-text]
27. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer.
    AJR Am J Roentgenol, 189(4): 830-44. [Abstract] [Full-text]
28. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Int J Radiat Oncol Biol Phys, 69(3): 839-45. [Abstract] [Full-text]
29. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
    Cancer, 110(7): 1542-50. [Abstract] [Full-text]
30. Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Int J Gynecol Cancer. [Abstract] [Full-text]
31. Quality of clinical practice guidelines in dermatological oncology.
    J Eur Acad Dermatol Venereol, 21(9): 1193-8. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.